Latest Insider Transactions at Olema Pharmaceuticals, Inc. (OLMA)
This section provides a real-time view of insider transactions for Olema Pharmaceuticals, Inc. (OLMA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Olema Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Olema Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 22
2023
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
SELL
Open market or private sale
|
Direct |
6,653
-1.15%
|
$86,489
$13.89 P/Share
|
|
Nov 22
2023
|
Naseem Zojwalla CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,095
-18.79%
|
$92,235
$13.89 P/Share
|
|
Nov 22
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
3,989
-0.42%
|
$51,857
$13.9 P/Share
|
|
Nov 21
2023
|
Shane William Charles Kovacs CH. OPERATING & FINANCIAL OFF. |
SELL
Open market or private sale
|
Direct |
9,597
-1.08%
|
$143,955
$15.05 P/Share
|
|
Nov 21
2023
|
Sean Bohen PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
29,293
-7.34%
|
$439,395
$15.07 P/Share
|
|
Nov 21
2023
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
SELL
Open market or private sale
|
Direct |
6,976
-0.59%
|
$104,640
$15.1 P/Share
|
|
Nov 21
2023
|
Naseem Zojwalla CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,461
-8.29%
|
$111,915
$15.08 P/Share
|
|
Nov 21
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
4,192
-0.44%
|
$58,688
$14.86 P/Share
|
|
Nov 20
2023
|
Shane William Charles Kovacs CH. OPERATING & FINANCIAL OFF. |
BUY
Grant, award, or other acquisition
|
Direct |
36,750
+7.65%
|
-
|
|
Nov 20
2023
|
Sean Bohen PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
110,250
+35.29%
|
-
|
|
Nov 20
2023
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+4.28%
|
-
|
|
Nov 20
2023
|
Naseem Zojwalla CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+38.24%
|
-
|
|
Nov 20
2023
|
Cyrus Harmon |
BUY
Grant, award, or other acquisition
|
Direct |
15,750
+1.62%
|
-
|
|
Nov 08
2023
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
SELL
Open market or private sale
|
Direct |
200
-0.04%
|
$3,400
$17.61 P/Share
|
|
Nov 03
2023
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
SELL
Open market or private sale
|
Direct |
541
-0.1%
|
$9,197
$17.51 P/Share
|
|
Nov 02
2023
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
SELL
Open market or private sale
|
Direct |
3,332
-0.59%
|
$49,980
$15.36 P/Share
|
|
Nov 02
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
5,000
-0.53%
|
$75,000
$15.64 P/Share
|
|
Nov 01
2023
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
SELL
Open market or private sale
|
Direct |
6,668
-1.17%
|
$100,020
$15.02 P/Share
|
|
Oct 31
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
25,000
-2.57%
|
$300,000
$12.05 P/Share
|
|
Sep 29
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
25,000
-2.5%
|
$300,000
$12.41 P/Share
|
|
Sep 19
2023
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
SELL
Open market or private sale
|
Direct |
20,000
-3.38%
|
$240,000
$12.67 P/Share
|
|
Sep 14
2023
|
Bvf Partners L P Director |
BUY
Other acquisition or disposition
|
Indirect |
99,556
+50.0%
|
-
|
|
Sep 12
2023
|
G. Walmsley Graham Director |
BUY
Open market or private purchase
|
Indirect |
508,130
+23.35%
|
$4,573,170
$9.84 P/Share
|
|
Sep 12
2023
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
1,505,932
+13.08%
|
$13,553,388
$9.84 P/Share
|
|
Sep 05
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
10,000
-0.99%
|
$110,000
$11.62 P/Share
|
|
Aug 31
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
15,000
-1.47%
|
$135,000
$9.36 P/Share
|
|
Aug 16
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
15,000
-1.44%
|
$150,000
$10.14 P/Share
|
|
Jun 08
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
10,000
-0.95%
|
$60,000
$6.3 P/Share
|
|
Jun 06
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
5,000
-0.47%
|
$30,000
$6.29 P/Share
|
|
Jun 05
2023
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
5,000
-0.47%
|
$30,000
$6.04 P/Share
|
|
Apr 06
2023
|
Shane William Charles Kovacs CH. OPERATING & FINANCIAL OFF. |
BUY
Open market or private purchase
|
Direct |
10,000
+2.46%
|
-
|
|
Sep 21
2022
|
Sean Bohen PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+21.21%
|
-
|
|
Sep 02
2022
|
Shane William Charles Kovacs CH. OPERATING & FINANCIAL OFF. |
BUY
Open market or private purchase
|
Direct |
20,000
+4.99%
|
-
|
|
Jun 10
2022
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
200,000
+2.65%
|
$800,000
$4.03 P/Share
|
|
Mar 10
2022
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,253
-68.12%
|
$21,012
$4.75 P/Share
|
|
Mar 10
2022
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,253
+40.52%
|
$10,506
$2.06 P/Share
|
|
Feb 10
2022
|
Kinney Horn Chief Business Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,251
-68.12%
|
-
|
|
Feb 10
2022
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,251
+40.52%
|
$10,502
$2.06 P/Share
|
|
Jan 10
2022
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,251
-68.12%
|
$31,506
$6.85 P/Share
|
|
Jan 10
2022
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,251
+40.52%
|
$10,502
$2.06 P/Share
|
|
Dec 10
2021
|
David C. Myles CH. DISCOV. & NON-CLIN DEV OFF |
SELL
Open market or private sale
|
Direct |
10,000
-1.69%
|
$100,000
$10.3 P/Share
|
|
Dec 10
2021
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
5,251
-68.12%
|
$52,510
$10.39 P/Share
|
|
Dec 10
2021
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,251
+40.52%
|
$10,502
$2.06 P/Share
|
|
Nov 30
2021
|
Bvf Partners L P Director |
BUY
Open market or private purchase
|
Direct |
739,675
+8.81%
|
$6,657,075
$9.39 P/Share
|
|
Nov 29
2021
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
400
-0.04%
|
$9,600
$24.76 P/Share
|
|
Nov 10
2021
|
Kinney Horn Chief Business Officer |
SELL
Open market or private sale
|
Direct |
27,668
-93.92%
|
$719,368
$26.88 P/Share
|
|
Nov 10
2021
|
Kinney Horn Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,668
+42.97%
|
$276,680
$10.53 P/Share
|
|
Oct 19
2021
|
Cyrus Harmon |
SELL
Open market or private sale
|
Direct |
12,000
-0.57%
|
$336,000
$28.03 P/Share
|
|
Oct 14
2021
|
Sean Bohen PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
5,000
-4.37%
|
$150,000
$30.8 P/Share
|
|
Oct 14
2021
|
Sean Bohen PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.0%
|
$20,000
$4.82 P/Share
|